Risperidone-induced mania: An emergent complication of treatment

Journal of Pharmacology and Pharmacotherapeutics

Volumn 5, Issue 4, 2014, Pages 258-260

  Kavoor, Anjana Rao ^a   Mitra, Sayantanava ^a   Mondal, Supriya Kumar ^b   Das, Basudeb ^a  

^a CENTRAL INSTITUTE OF PSYCHIATRY   (India)

^b Murshidabad Medical College and Hospital   (India)

Author keywords

Mania; Risperidone; Side effect

Indexed keywords

CARBAMAZEPINE; LITHIUM CARBONATE; RISPERIDONE; TRIHEXYPHENIDYL;

ACUTE PSYCHOSIS; ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; COMMUNICATION DISORDER; DISEASE COURSE; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DYSPHORIA; EUPHORIA; FEAR; FOLLOW UP; HUMAN; ICD-10; LITHIUM BLOOD LEVEL; MAINTENANCE DRUG DOSE; MALE; MANIA; MENTAL INSTABILITY; MENTAL TEST; MIDDLE AGED; PERCEPTION DISORDER; PERSECUTORY DELUSION; PERSONALITY DISORDER; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SYMPTOM; THOUGHT DISORDER; TRANSIENT PSYCHOTIC DISORDER; UNDIFFERENTIATED SCHIZOPHRENIA; YOUNG MANIA RATING SCALE;

EID: 84908574599     PISSN: 0976500X     EISSN: 09765018     Source Type: Journal    
DOI: 10.4103/0976-500X.142448     Document Type: Article

References (11)

1. Michalopoulou PG, Lykouras L. Manic/hypomanic symptoms induced by atypical antipsychotics: A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 549-64.
2. Richelson E. Receptor pharmacology of neuroleptics: Relation to clinical effects. J Clin Psychiatry 1999; 60 Suppl 10: 5-14.
3. Yatham LN. Acute and maintenance treatment of bipolar mania: The role of atypical antipsychotics. Bipolar Disord 2003; 5 Suppl 2: 7-19.
4. Masan PS. Atypical antipsychotics in the treatment of affective symptoms: A review. Ann Clin Psychiatry 2004; 16: 3-13.
5. Mensink GJ, Slooff CJ. Novel antipsychotics in bipolar and schizoaffective mania. Acta Psychiatr Scand 2004; 109: 405-19.
6. Barbee JG, Conrad EJ, Jamhour NJ. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder. J Clin Psychiatry 2004; 65: 975-81.
7. Zhang W, Perry KW, Wong DT, Potts BD, Bao J, Tollefson GD, et al. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 2000; 23: 250-62.
8. Lane HY, Lin YC, Chang WH. Mania induced by risperidone: Dose related? J Clin Psychiatry 1998; 59: 85-6.
9. Meltzer HY, Matsubara S, Lee JC. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 1989; 25: 390-2.
10. Remington G, Kapur S. D2 and 5-HT2 receptor effects of antipsychotics: Bridging basic and clinical findings using PET. J Clin Psychiatry 1999; 60 Suppl 10: 15-9.
11. Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY. 5-HT (2A) and D (2) receptor blockade increases cortical DA release via 5-HT (1A) receptor activation: A possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 2001; 76: 1521-31.